308 related articles for article (PubMed ID: 7202494)
41. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
42. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
[No Abstract] [Full Text] [Related]
43. Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland.
Lightman SL; Ninkovic M; Hunt SP
Neurosci Lett; 1982 Oct; 32(2):99-102. PubMed ID: 7145239
[TBL] [Abstract][Full Text] [Related]
44. 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus.
Creese I; Snyder SH
Eur J Pharmacol; 1978 May; 49(2):201-2. PubMed ID: 658137
[No Abstract] [Full Text] [Related]
45. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
Howlett DR; Morris H; Nahorski SR
Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
[No Abstract] [Full Text] [Related]
46. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
Noguchi-kuno SA; Nakata C; Nishitani H
Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
[No Abstract] [Full Text] [Related]
47. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
48. Chronic proglumide increases [3H]spiperone binding in the rat brain.
Bean AJ; Baldy WJ; Martin GE
Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
[TBL] [Abstract][Full Text] [Related]
49. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
Hall H; Wedel I
Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
[TBL] [Abstract][Full Text] [Related]
50. Septo-hippocampal system: target for substituted benzamides.
Bischoff S; Bittiger H; Delini-Stula A; Ortmann R
Eur J Pharmacol; 1982 Apr; 79(3-4):225-32. PubMed ID: 7201401
[TBL] [Abstract][Full Text] [Related]
51. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
52. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
Cronin MJ; Reches A; MacLeod RM; Login IS
Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
[TBL] [Abstract][Full Text] [Related]
53. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
Köhler C; Haglund L; Ogren SO; Angeby T
J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
[TBL] [Abstract][Full Text] [Related]
54. Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine.
Nielsen EB; Nielsen M; Ellison G; Braestrup C
Eur J Pharmacol; 1980 Aug; 66(2-3):149-54. PubMed ID: 7439269
[TBL] [Abstract][Full Text] [Related]
55. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
[TBL] [Abstract][Full Text] [Related]
56. Dietary lithium during development: changes in amino acid levels, ionic content, and [3H]spiperone binding in the brain of rats.
Wajda IJ; Banay-Schwartz M; De Guzman T; Manigault I
Neurochem Res; 1983 May; 8(5):637-48. PubMed ID: 6412150
[TBL] [Abstract][Full Text] [Related]
57. Autoradiographic mapping of spirodecanone binding-sites in the hippocampal region of the rat. Evidence for a localization on intrinsic neurons.
Köhler C
Neurosci Lett; 1984 May; 46(2):179-84. PubMed ID: 6330621
[TBL] [Abstract][Full Text] [Related]
58. Effects of phospholipids on the specific binding of [3H]spiroperidol to the cholate extract of rat brain synaptic membranes.
Moroi K; Hsu LL
Int J Biochem; 1985; 17(5):637-44. PubMed ID: 4029482
[TBL] [Abstract][Full Text] [Related]
59. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
60. In vitro evaluation of radioiodinated butyrophenones as radiotracer for dopamine receptor study.
Nakatsuka I; Saji H; Shiba K; Shimizu H; Okuno M; Yoshitake A; Yokoyama A
Life Sci; 1987 Oct; 41(17):1989-97. PubMed ID: 2959832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
